← Back to Search

Elastography Device

Liver Incytes System for Non-alcoholic Fatty Liver Disease

N/A
Waitlist Available
Research Sponsored by Sonic Incytes
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trialcompares different non-invasive techniques to measure stiffness in the liver, to find the most effective way.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Liver Fibrosis
  • Non-alcoholic Fatty Liver Disease
  • Fatty Liver

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determination of Liver Incytes' discriminatory ability of liver stiffness as measured by fibrosis staging
Elasticity measurements comparison between Liver Incytes MR Elastography
Secondary outcome measures
Liver extract
Comparison between Liver Incytes' and FibroScan's fibrosis staging capabilities
Comparison between Liver Incytes' and FibroScan's steatosis staging capabilities
+2 more
Other outcome measures
Identification of cases in which FibroScan may overestimate or underestimate fat content
Identification of cases in which FibroScan may overestimate or underestimate liver stiffness
Liver extract
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Open-labelExperimental Treatment1 Intervention
Volunteers who have agreed to participate in the study will have their liver scanned using the FibroScan, VE (Liver Incytes System) and MRE techniques.

Find a Location

Who is running the clinical trial?

Sonic IncytesLead Sponsor
5 Previous Clinical Trials
546 Total Patients Enrolled
3 Trials studying Non-alcoholic Fatty Liver Disease
336 Patients Enrolled for Non-alcoholic Fatty Liver Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is senior-aged individuals being accepted into this clinical trial?

"Per the trial's criteria for eligibility, individuals must be between 19 and 75 years of age to qualify."

Answered by AI

Is enrollment still ongoing for this experiment?

"At present, clinicaltrials.gov does not list this study as actively recruiting participants. Initially posted on October 21st 2020, the listing was last updated December 7th 2022. Despite being closed for recruitment at this time, there are currently 773 other trials open to patient enrollment."

Answered by AI

What is the primary purpose of this clinical experiment?

"According to Sonic Incytes, the principal aim of this 12-month clinical trial is assessing Liver Incytes' diagnostic ability in regards to fibrosis staging. Furthermore, secondary objectives include ascertaining the occurrence and technical issues with devices; establishing whether attenuation measurements from MRI Proton Density Fat Fraction and Liver Incytes System are comparable using a concordance correlation coefficient and 95% confidence intervals; as well as comparing FibroScan's elasticity (kPa) readings with those collected by Liver Incyte’s system against Magnetic Resonance Elastography (MRE) results for constructing Receiver Operating Curves"

Answered by AI

Is there a possibility of my participation in this clinical research?

"For this research study, volunteers need to be between 19 and 75 years old with a diagnosis of fibrosis. A total of 164 participants are being recruited for the trial."

Answered by AI
~36 spots leftby Apr 2025